Pharmaceuticals, Biotechnology and Life Sciences
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP, OTCQB: ASPF) today announced that it has commenced litigation against Recipharm…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP, OTCQB: ASPF) today announced that it has commenced litigation against Recipharm…
ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer,…
ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer,…
ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer,…
IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences (Nasdaq: UROV) today reported financial results for the three months and 2019 fiscal…
IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences (Nasdaq: UROV) today reported financial results for the three months and 2019 fiscal…
IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences (Nasdaq: UROV) today reported financial results for the three months and 2019 fiscal…
Findings presented during the developmental therapeutics session at the ASCO 2020 Virtual Scientific Program CULVER CITY, Calif.–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ:…
Findings presented during the developmental therapeutics session at the ASCO 2020 Virtual Scientific Program CULVER CITY, Calif.–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ:…